S-17092

S-17092

S-17092 is a pharmacological compound that is classified as a piperazine derivative. It is known for its potential therapeutic effects in the treatment of cognitive impairment and schizophrenia.

Chemistry

S-17092 is a synthetic compound that belongs to the class of piperazine derivatives. It is characterized by its unique chemical structure, which includes a piperazine ring, a benzyl group, and a phenyl group. The compound's chemical formula is C17H21N3O2, and its molecular weight is 297.37 g/mol.

Pharmacology

The pharmacological properties of S-17092 are primarily attributed to its ability to modulate the activity of serotonin receptors in the brain. Specifically, S-17092 acts as a partial agonist at the 5-HT1A receptor, a subtype of serotonin receptor that plays a crucial role in regulating mood, cognition, and other neurological functions.

Therapeutic Potential

S-17092 has been investigated for its potential therapeutic effects in the treatment of cognitive impairment and schizophrenia. Preclinical studies have shown that the compound can improve cognitive performance in animal models of these disorders. However, further research is needed to confirm these findings in human clinical trials.

Safety and Tolerability

The safety and tolerability of S-17092 have been evaluated in preclinical studies. The compound has been found to be well-tolerated in animal models, with no significant adverse effects reported at therapeutic doses. However, the safety profile of S-17092 in humans has not yet been fully established.

Research

Research on S-17092 is ongoing, with scientists continuing to explore its pharmacological properties and potential therapeutic applications. Future studies may provide further insights into the compound's mechanism of action, efficacy, and safety profile.

See Also

• Piperazine
• Serotonin
• 5-HT1A receptor
• Cognitive impairment
• Schizophrenia

‎

‎

‎

‎